Evidence map›Paper›PMID 41369358›Full record

ReviewCells2025

Reciprocal Paracrine Signaling and Dynamic Coordination of Transitional States in the Alveolar Epithelial Type 2 Cells and Associated Alveolar Lipofibroblasts During Homeostasis, Injury and Repair.

Georgios-Dimitrios Panagiotidis, Mengqing Chen, Xiuyue Yang, Manuela Marega, Stefano Rivetti, Xuran Chu, Saverio Bellusci

Abstract readReview
In one paragraph

Review in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Georgios-Dimitrios PanagiotidisDepartment of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig University Giessen (JLU), 35392 Giessen, Germany.ORCID 0009-0001-3578-6344
Mengqing ChenDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Xiuyue YangSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou 325035, China.
Manuela MaregaDepartment of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig University Giessen (JLU), 35392 Giessen, Germany.ORCID 0009-0005-5015-4280
Stefano RivettiDepartment of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig University Giessen (JLU), 35392 Giessen, Germany.
Xuran ChuSchool of Pharmaceutical Science, Wenzhou Medical University, Wenzhou 325035, China.
Saverio BellusciDepartment of Pulmonary and Critical Care Medicine, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China.ORCID 0000-0001-5987-4579

Funding

Deutsche Forschungsgemeinschaft BE4443/18-1
6 · The paper itself

Abstract

Single-cell RNA-sequencing has transformed our understanding of alveolar epithelial type 2 (AT2) cells and alveolar lipofibroblasts (LIFs) during lung injury and repair. Both cell types undergo dynamic transitions through intermediate states that determine whether the lung proceeds toward regeneration or fibrosis. Emerging evidence highlights reciprocal paracrine signaling between AT2/AT1 transitional cells and LIF-derived myofibroblasts (aMYFs) as a key regulatory axis. Among these, amphiregulin (AREG)-EGFR signaling functions as a central profibrotic pathway whose inhibition can restore alveolar differentiation and repair. The

Indexed as

Alveolar Epithelial CellsFibroblastsHomeostasisLung InjuryParacrine CommunicationAnimalsHumansRegenerationalveolar regenerationAREG–EGFR signalingAT2/AT1 transitional cellsfibrosis resolutionlipofibroblast–myofibroblast (LIF–MYF) switchWI-38 fibroblast model

Identifiers

PMID41369358
PMCPMC12691163

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.